BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22417854)

  • 1. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
    Elmoneim HM; Samaka RM; Ali H
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
    Salmenkivi K; Arola J; Voutilainen R; Ilvesmäki V; Haglund C; Kahri AI; Heikkilä P; Liu J
    J Clin Endocrinol Metab; 2001 May; 86(5):2231-5. PubMed ID: 11344232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
    Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
    Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
    Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
    Feng C; Li HZ; Yan WG; Luo YF; Cao JL
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of inhibin/activin subunits in the human adrenal cortex and its tumours.
    Munro LM; Kennedy A; McNicol AM
    J Endocrinol; 1999 May; 161(2):341-7. PubMed ID: 10320833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms.
    Cho EY; Ahn GH
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):222-8. PubMed ID: 11556749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
    Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
    J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
    Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
    Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
    Marino FE; Risbridger G; Gold E
    Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
    Sangoi AR; McKenney JK
    Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies.
    Mylonas I; Schiessl B; Jeschke U; Vogl J; Makrigiannakis A; Kuhn C; Schulze S; Kainer F; Friese K
    Endocr Pathol; 2006; 17(1):19-33. PubMed ID: 16760577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal cortical tumors, pheochromocytomas and paragangliomas.
    Lloyd RV
    Mod Pathol; 2011 Apr; 24 Suppl 2():S58-65. PubMed ID: 21455202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits.
    Cobellis L; Cataldi P; Reis FM; De Palo G; Raspagliesi F; Pilotti S; Arcuri F; Petraglia F
    Eur J Endocrinol; 2001 Dec; 145(6):779-84. PubMed ID: 11720904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
    Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
    Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques].
    Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study.
    Fogt F; Zimmerman RL; Mulligan N; Vortmeyer AO; Poremba C; Harris CA; Alsaigh N; Tomaszewski JE; Nikulasson ST
    Int J Mol Med; 1999 Mar; 3(3):271-4. PubMed ID: 10028050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
    Mylonas I
    Arch Gynecol Obstet; 2011 Aug; 284(2):467-76. PubMed ID: 20865419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.